Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) (C-Term) Peptide
Quick Overview for Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1) (C-Term) Peptide (ABIN979691)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- HERLVWKEEK EKVIQYQRQL QQSYLAMYQR NQRLEKALQQ LARGDGPGEP
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-Lzts1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LZTS1 (Leucine Zipper, Putative Tumor Suppressor 1 (LZTS1))
-
Background
-
Lzts1 is involved in the regulation of cell growth. It may stabilize the active CDC2-cyclin B1 complex and thereby contribute to the regulation of the cell cycle and the prevention of uncontrolled cell proliferation. It may act as tumor suppressor.
Alias Symbols: F37, FEZ1
Protein Size: 599 -
Molecular Weight
- 67 kDa
-
Gene ID
- 211134
-
NCBI Accession
- NM_199364, NP_955396
-
UniProt
- P60853
Target
-